Iskalni niz je ali predolg ali pa vsebuje preveč besed.
Prevodi: en > sl
1–11/11
N0
1 Pravna redakcija
obramba
CELEX: 31993R0793
[2-(acryloyloxy)ethyl]trimethylammonium chloride C 8 H 16 N0 2 ·Cl
[2-(akriloiloksi)etil]trimetilamonijev klorid C 8 H 16 N0 2 ·Cl
2 Pravna redakcija
DRUGO
[2-(acryloyloxy)ethyl]trimethylammonium chloride C 8 H 16 N0 2 ·Cl
[2-(akriloiloksi)etil]trimetilamonijev klorid C 8 H 16 N0 2 ·Cl
3 Pravna redakcija
DRUGO
The relation between "noise level" expressed in peak-to-peak is given by S2pp = 8N0(f2-f1), where Spp is the peak-to-peak value of the signal (e.g., nanoteslas), N0 is the power spectral density (e.g., (nanotesla)2/Hz) ana (f2 f1) defines the bandwidth of interest.
Razmerje med "šumnim nivojem", izraženim s pozitivno in negativno največjo vrednostjo, je S2pp = 8No(f2-f1), pri čemer je Spp maksimalna vrednost signala (tj. nanotesla), No je moč spektralne gostote (tj. (nanotesla)2/Hz), (f2-f1) pa zadevni frekvenčni pas.
4 Prevajalska redakcija
izobraževanje
CELEX: 31992L0069
N0 = number of cells/ml at time t0 (beginning of the test),0,
N0 = število celic/ml ob času t0 (začetek preskusa),
5 Prevajalska redakcija
izobraževanje
CELEX: 31996L0044
n0 = air density at the reference conditions (20 °C, 100 kPa)
ρ0 = gostota zraka pri referenčnih pogojih (20 °C, 100 kPa)
6 Prevajalska redakcija
izobraževanje
CELEX: 31996L0044
K = RR RT. [1 + KR(t - t0)] + RAERO RT. (n0) n
R t − t R R ρ 0ρ
7 Prevajalska redakcija
izobraževanje
CELEX: 31992L0069
Ac = area between the control growth curve and the horizontal line N = N0.
Ac = površina med rastno krivuljo kontrolne kulture in vodoravno premico N = N0.
8 Prevajalska redakcija
izobraževanje
CELEX: 31992L0069
At = area between the growth curve at the concentration t and the horizontal line N = N0.
At = površina med rastno krivuljo pri koncentraciji t in vodoravno premico N = N0.
9 Prevajalska redakcija
izobraževanje
CELEX: 31992L0069
The area between the growth curves and the horizontal line N = N0 may be calculated according to the formula:
Površina med rastno krivuljo in vodoravno premico N = N0 se lahko izračuna po naslednji enačbi: A = N + N - 2N × N + N - 2N ×
10 Prevajalska redakcija
RS
EMEA
Bicalutamide 150 mg was studied as a treatment for patients with localized (T1-T2, N0 or NX, M0) or locally advanced (T3-T4, any N, M0; T1-T2, N+, M0) non-metastatic prostate cancer, in a combined analysis of 3 placebo-controlled double-blind studies in 8,113 patients, where the product was given as immediate hormone therapy or as adjuvant to radical prostatectomy or radiotherapy (primarily external beam radiation).
Bikalutamid v odmerku 150 mg je bil proučevan kot terapija za bolnike z lokaliziranim (T1- T2, N0 ali NX, M0) ali lokalno napredovalim (T3- T4, katerikoli N, M0; T1- T2, N+, M0) nemetastatskim rakom prostate v kombinirani analizi treh s placebom kontroliranih, dvojno slepih študij pri 8113 bolnikih. Bikalutamid je bil uporabljen kot takojšnja hormonska terapija ali kot adjuvantna terapija poleg radikalne prostatektomije ali radioterapije (v prvi vrsti z zunanjim obsevanjem).
11 Prevajalska redakcija
RS
EMEA
CASODEX (Bicalutamide) 150 mg was studied as a treatment for patients with localised (T1-T2, N0 or NX, M0) or locally advanced (T3-T4, any N, M0; T1-T2, N+, M0) non-metastatic prostate cancer in a combined analysis of 3 placebo controlled double-blind studies in 8113 patients, where CASODEX was given as immediate hormonal therapy or as adjuvant to radical prostatectomy or radiotherapy, (primarily external beam radiation).
CASODEX (bikalutamid) 150 mg je bil preučevan kot terapija za bolnike z lokaliziranim (T1– T2, N0 ali NX, M0) ali lokalno napredovalim (T3– T4, katerikoli N, M0; T1– T2, N+, M0) nemetastatskim rakom prostate v kombinirani analizi treh s placebom kontroliranih, dvojno slepih študij pri 8113 bolnikih. CASODEX je bil uporabljen kot takojšnja hormonska terapija ali kot adjuvantna terapija poleg radikalne prostatektomije ali radioterapije (v prvi vrsti z zunanjim obsevanjem).
Prevodi: en > sl
1–11/11
N0